Paul Bisaro
Equibles does not estimate personal net worth.
About Paul Bisaro
Paul Bisaro was last confirmed as Chairman at Amneal Pharmaceuticals, Inc. (AMRX) in a filing dated March 23, 2020. The proxy statement of Amneal Pharmaceuticals, Inc. reports total compensation of $4,119,314 for Paul Bisaro in fiscal 2019, including a base salary of $503,607. Disclosed compensation is on record for 3 fiscal years.
Affiliation history
-
Start not stated–2020-03-23
Last confirmed by a filing; no departure on record
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Amneal Pharmaceuticals, Inc. (AMRX) | Former Executive Chairman | $503,607 | $4,119,314 |
| 2018 | Amneal Pharmaceuticals, Inc. (AMRX) | Former Executive Chairman | $802,885 | $6,066,025 |
| 2017 | Amneal Pharmaceuticals, Inc. (AMRX) | Former Executive Chairman | $621,154 | $6,532,512 |
Recent activity
No call appearances or filed executive changes recorded yet.